<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="pntd.0008143.t001" orientation="portrait" position="float">
 <object-id pub-id-type="doi">10.1371/journal.pntd.0008143.t001</object-id>
 <label>Table 1</label>
 <caption>
  <title>The frequency distribution of the lesion patterns in the different experimental groups shows a trend to a more favourable outcome (pattern C) in the combined treatment groups.</title>
 </caption>
 <alternatives>
  <graphic id="pntd.0008143.t001g" xlink:href="pntd.0008143.t001" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  <table frame="hsides" rules="groups">
   <colgroup span="1">
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
   </colgroup>
   <thead>
    <tr>
     <th align="left" rowspan="2" colspan="1">Group</th>
     <th align="center" colspan="3" rowspan="1">Pattern</th>
    </tr>
    <tr>
     <th align="center" rowspan="1" colspan="1">A</th>
     <th align="center" rowspan="1" colspan="1">B</th>
     <th align="center" rowspan="1" colspan="1">C</th>
    </tr>
   </thead>
   <tbody>
    <tr>
     <td align="left" rowspan="1" colspan="1">Gn3 T1 group</td>
     <td align="right" rowspan="1" colspan="1">33.33%</td>
     <td align="right" rowspan="1" colspan="1">8.33%</td>
     <td align="right" rowspan="1" colspan="1">58.33%</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Gn3 T2 group</td>
     <td align="right" rowspan="1" colspan="1">41.67%</td>
     <td align="right" rowspan="1" colspan="1">16.67%</td>
     <td align="right" rowspan="1" colspan="1">41.67%</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Gn3+Gn32 combi T1 group</td>
     <td align="right" rowspan="1" colspan="1">16.67%</td>
     <td align="right" rowspan="1" colspan="1">16.67%</td>
     <td align="right" rowspan="1" colspan="1">66.67%</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Gn3+Gn32 combi T2 group</td>
     <td align="right" rowspan="1" colspan="1">0%</td>
     <td align="right" rowspan="1" colspan="1">9.09%</td>
     <td align="right" rowspan="1" colspan="1">90.91%</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">PBS group</td>
     <td align="right" rowspan="1" colspan="1">70.83%</td>
     <td align="right" rowspan="1" colspan="1">8.33%</td>
     <td align="right" rowspan="1" colspan="1">20.83%</td>
    </tr>
   </tbody>
  </table>
 </alternatives>
 <table-wrap-foot>
  <fn id="t001fn001">
   <p>Pattern A: “Early-onset fatal hepatitis” characterized by severe, acute, coalescing to diffuse hepatitis and RVFV-antigen mainly in hepatocytes, as well as lymphocytic depletion; Pattern B: “Late-onset fatal polioencephalitis” characterized by mild to moderate, acute, focal to multifocal, necrotizing polioencephalitis and RVFV-antigen within neuroglial cells, as well as variable, subacute hepatitis and lymphocytic depletion; Pattern C: “Survivor with reactive lymphoid hyperplasia” characterized by mild to moderate, subacute to chronic, follicular hyperplasia in the spleen, as well as mild, subacute hepatitis or periportal infiltration and/or no obvious lesions.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
